About
Beren Therapeutics is a public benefit corporation developing investigational drugs for rare diseases, including Adrabetadex for Infantile-Onset Niemann-Pick Disease, Type C.
Explore Beren Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.